1597 Finalised International Active Surveillance study - Folate and Oral Contraceptive Utilization Study (INAS-FOCUS) Yes Yes 1613 Finalised International Active Surveillance Study of Women Taking Dienogest for Endometriosis: Visanne Post-approval Observational Study (VIPOS) Yes Yes 2679 Finalised SURVEILLANCE STUDY OF PHOTOCONTACT DERMATITIS LEADING TO HOSPITALIZATION IN EUROPE WITH A SPECIAL FOCUS ON TOPICAL KETOPROFEN AND OTHER TOPICAL... Yes No 3911 Finalised Xarelto (Rivaroxaban) Risk Minimisation Plan Evaluation: Patient and Physician Knowledge of Key Safety Messages Yes Yes 3979 Finalised An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban... Yes Yes 4564 Finalised OPTIMIS - Outcomes of HCC patients treated with TACE followed or not followed by sorafenib and the influence of timing to initiate sorafenib Yes Yes 4934 Finalised RECORA- Regorafenib in patients with metastatic colorectal cancer (mCRC) after failure of standard therapy Yes Yes 5944 Finalised Correlate - Safety and Effectiveness of Regorafenib in Routine Clinical Practice Settings Yes Yes 6115 Finalised EXPERT, EXPosurE Registry RiociguaT in patients with pulmonary hypertension Yes Yes 6476 Ongoing European Active Surveillance Study of LCS12 (EURAS-LCS12) Yes No 7187 Ongoing Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation (REASSURE) Yes No 8365 Finalised Drug Utilization Study on the Prescribing Indications for CPA/EE in 5 European Countries Yes Yes 8412 Finalised Drug utilization study of cyproterone/ethinylestradiol (Diane®-35 and generics) in the Netherlands, UK and Italy Yes Yes 8494 Finalised A Drug Utilization Study of Xofigo Use in Sweden Yes Yes 8498 Finalised Pharmacoepidemiological study (Drug Utilization Study) of JAYDESS use in routine clinical practice in Sweden (Jaydess DUS) Yes Yes 9020 Finalised PARABO - Pain evaluation in Radium-223 (Xofigo®) treated mCRPC patients with bone metastases – a non-interventional study in nuclear medicine centers Yes Yes 9312 Finalised Study to Evaluate Physician Knowledge of Safety and Safe Use Information for Diane-35 and Its Generics in Europe: An Observational Post-Authorisation... Yes Yes 9895 Finalised A pharmacoepidemiological study of rivaroxaban use and potential adverse outcomes in routine clinical practice in Sweden Yes Yes 9977 Finalised An Observational Post-authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of rivaroxaban... Yes Yes 9991 Finalised Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: An Observational Postauthorisation Study Yes Yes 10249 Finalised BETAPREDICT - MS patients treated with BETAferon®: PREDICTors of treatment adherence Yes Yes 10837 Finalised A pharmacoepidemiological study on the risk of bleeding in new users of low-dose aspirin (ASA) in The Health Improvement Network (THIN), UK (EPISAT) Yes Yes 11141 Finalised A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in the Netherlands Yes Yes 11145 Finalised A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in Germany Yes Yes 11299 Finalised A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in the United Kingdom Yes Yes 12608 Finalised COSIMO Cancer associated thrombosis - patient reported outcomes with rivaroxaban. A non-interventional study on patients changing to Xarelto® for... Yes Yes 12665 Finalised Second primary cancers in patients with castration resistant prostate cancer (BOCARP) Yes Yes 13054 Finalised EPID Multiple Sclerosis Pregnancy study - Pregnancy outcomes in Multiple Sclerosis populations exposed and unexposed to interferon beta - a... Yes Yes 13602 Finalised Incidence of Second Primary Malignancies in Patients With Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US Yes Yes 14567 Finalised Benefit-Risk Of arterial THrombotic prEvention with Rivaroxaban for atrial fibrillation in daily clinical practice. A French cohort within the... Yes Yes 15459 Finalised A Multinational Phase IV Study Evaluating “Real World” Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog... Yes Yes 15491 Finalised Incidence of Second primary Malignancies in prostate Cancer patients with bone metastases – an observational retrospective cohort study in Sweden... Yes Yes 15687 Finalised A prospective observational study conducted in France to describe routine clinical practice for treatment naïve or previously treated patients with... Yes Yes 15755 Finalised Real-world comparative effectiveness of stroke prevention in patients with atrial fibrillation treated with rivaroxaban vs. vitamin k antagonists... Yes Yes 15961 Finalised An observational post-authorization Modified Prescription-Event Monitoring safety study to monitor the safety and utilization of rivaroxaban... Yes Yes 18521 Finalised Pattern of use of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation patients in UK general practices Yes Yes 20981 Finalised REFINE: Regorafenib observational study in hepatocellular carcinoma Yes Yes 21253 Finalised Evaluation of Clinical outcomes among non-valvular atrial fibrillatIon patients with renal dysfunction treated with warfarin or reduced dose... Yes Yes 21800 Finalised Comparative effectiveness of rivaroxaban and warfarin for stroke prevention in multi-morbid patients with nonvalvular atrial fibrillation Yes Yes 23099 Finalised Treatment Pattern of NOACs (non-vitamin K oral anticoagulants) in Outpatient Users in Colombian Databases - TREND Colombia Yes Yes 23347 Finalised Association between the Prevalence of cardiovascular risk factors and new use of testosterone Yes Yes 23407 Finalised Treatment and outcomes among patients with atrial fibrillation and acute coronary syndrome in Sweden Yes Yes 24270 Finalised Real-world comparative effectiveness of stroke prevention in patients with atrial fibrillation treated with Factor Xa nonvitamin-K oral anticoagulants... Yes Yes 24796 Finalised URANIS –Data collection in urological centers during treatment with Ra-223 dichloride (Xofigo) within the framework of a non-interventional study... Yes Yes 25089 Finalised Risk of anaphylactoid reactions of Iopromide after intra-arterial administration (UVIA Study) Yes Yes 26416 Ongoing Observational Study Evaluating Effectiveness and Safety of Real-World Treatment with Damoctocog alfa pegol in Previously Treated Patients with... Yes No 26922 Finalised Risk association of orofacial cleft and glucocorticoids exposure during pregnancy: a meta-analysis (GC_OC) Yes No 28126 Finalised Non-traumatic Haemorrhagic Adverse Events: A Cross-sectional Study in Emergency Departments (HARER) No Yes 28234 Finalised Safety and Effectiveness of Rivaroxaban and Apixaban compared to warfarin in non-valvular atrial fibrillation patients in the routine clinical... Yes Yes 29848 Finalised PRostAte Cancer vTe In SwEden: epidemiology and anticoagulation treatment of VTE (PRACTISE) Yes Yes 30727 Finalised Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up... Yes Yes 31146 Ongoing Epidemiology, treatment and healthcare utilization in patients with diabetes mellitus – a population-based observational study using data from the... No No 31734 Ongoing Darolutamide Observational Study in non-metastatic castration-resistant prostate cancer patients (DAROL) No No 32136 Ongoing PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib (ON-TRK) Yes No 32349 Finalised Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry (XARENO-Registry) Yes Yes 33167 Ongoing Real-world evidence for non-valvular atrial fibrillation patients treated with oral anticoagulation in the Nordics (REATTAIN) Yes No 33448 Finalised PRECISE/Rates of bone fractures and survival in metastatic castration-resistant PRostate cancer (mCRPC) PatiEnts treated with Radium-223 in routine... Yes Yes 33461 Finalised Study on the association of uterine perforation and intrauterine device (IUD) expulsion with breastfeeding status at the time of IUD insertion and... Yes Yes 33520 Ongoing Observational study evaluating long-term safety of real-world treatment with damoctocog alfa pegol in previously treated patients with hemophilia A... Yes No 33537 Finalised Adverse ReNal OuTcomEs in patients with NoN-Valvular Atrial fibrillation treated with Rivaroxaban or Vitamin K Antagonists (ANTENNA) Yes Yes 33562 Finalised Incidence and Trend of Ectopic Pregnancy 2009-2018 - A population-based Study Yes Yes 36102 Finalised Real-world comparative effectiveness of rivaroxaban versus heparin and phenprocoumon for the treatment and secondary prevention of venous... Yes Yes 36634 Finalised RIVA-DM: Effectiveness and Safety of Rivaroxaban vs. Warfarin in Nonvalvular Atrial Fibrillation and Diabetes Mellitus: Analysis of Electronic Health... Yes Yes 37163 Finalised Drug utilisation study of Radium 223 under routine clinical practice in Europe (DIRECT) Yes Yes 37597 Finalised Safety profile of Ultravist in children and elderly (UV Age) Yes Yes 38736 Planned INFORM - Interferon-Beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-Based Drug Utilisation Study in Finland and Sweden Yes No 39592 Ongoing Effectiveness and safety of non-vitamin K anticoagulants (NOACs) versus warfarin in frail patients with nonvalvular atrial fibrillation (AF): a... No No 41194 Finalised Study to Evaluate Physician Awareness and Knowledge of Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Monotherapies in... Yes Yes 43329 Finalised Observational Studies in Cancer Associated Thrombosis for Rivaroxaban – United Kingdom Cohort (OSCAR—UK) Yes Yes 43355 Finalised Observational Studies in Cancer Associated Thrombosis for Rivaroxaban in SwEden (OSCAR-SE) Yes Yes 46493 Ongoing FINE-REAL: Non-interventional study to collect real-world data and providing insights into the use of finerenone in routine clinical practice Yes No 46800 Planned Xarelto Paediatric VTE PASS Drug Utilization Study: An observational, longitudinal, multi-source drug utilization safety study to evaluate the drug... Yes No 47805 Finalised Safety profile of Ultravist in patients with different sexes, races and from different countries/regions Yes Yes 48148 Ongoing FINErenone druG Utilization Study and assessment of Temporal changes following availability of different treatment options in patients with chronic... Yes No 105067 Ongoing Effectiveness and safety of low dose rivaroxaban plus aspirin in patients with Chronic Coronary Syndrome and high ischemic risk. (Dutch CCS Registry) No No